Document:

Exhibit 10.35

 

ORGANOGENESIS HOLDINGS INC.

AMENDED AND RESTATED CODE OF ETHICS AND CONDUCT

 

Adopted [·], 2018

 

In accordance with the requirements of the Securities and Exchange Commission (the “SEC”) and the National Association of Securities Dealers Automated Quotations Stock Market (“Nasdaq”) Listing Standards, the Board of Directors (the “Board”) of Organogenesis Holdings Inc. (the “Company”) has adopted this Amended and Restated Code of Ethics and Conduct (the “Code”) to encourage:

 

·                  Honest and ethical conduct, including fair dealing and the ethical handling of actual or apparent conflicts of interest;

 

·                  Full, fair, accurate, timely and understandable disclosure;

 

·                  Compliance with applicable governmental laws, rules and regulations;

 

·                  Prompt internal reporting of any violations of law or the Code;

 

·                  Accountability for adherence to the Code, including fair process by which to determine violations;

 

·                  Consistent enforcement of the Code, including clear and objective standards for compliance;

 

·                  Protection for persons reporting any such questionable behavior;

 

·                  The protection of the Company’s legitimate business interests, including its assets and corporate opportunities; and

 

·                  Confidentiality of information entrusted to directors, officers and employees by the Company and its customers.

 

All directors, officers and employees (each a “Covered Party” and, collectively, the “Covered Parties”) of the Company and all of its subsidiaries and controlled affiliates are expected to be familiar with the Code and to adhere to those principles and procedures set forth below. Covered Parties must conduct themselves accordingly, exhibiting the highest standard of business and professional integrity, and seek to avoid even the appearance of improper behavior.

 

I.                                        Conflicts of Interest

 

A conflict of interest occurs when the private interests of a Covered Party interfere, or appear to interfere, with the interests of the Company as a whole.

 

For example, a conflict of interest can arise when a Covered Party takes actions or has personal interests that may make it difficult to perform his or

 

 

her Company duties objectively and effectively. A conflict of interest may also arise when a Covered Party, or a member of his or her immediate family(1), receives improper personal benefits as a result of his or her position at the Company.

 

Conflicts of interest can also occur indirectly. For example, a conflict of interest may arise when a Covered Party is also an executive officer, a major stockholder or has a material interest in a company or organization doing business with the Company.

 

Each Covered Party has an obligation to conduct the Company’s business in an honest and ethical manner, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships. Any situation that involves, or may reasonably be expected to involve, a conflict of interest with the Company, should be disclosed promptly to the Company’s Audit Committee or the Company’s General Counsel.

 

This Code does not attempt to describe all possible conflicts of interest that could develop. Other common conflicts from which Covered Parties must refrain are set out below:

 

·                  Covered Parties may not engage in any conduct or activities that are inconsistent with the Company’s best interests or that disrupt or impair the Company’s relationship with any person or entity with which the Company has or proposes to enter into a business or contractual relationship.

 

·                  Covered Parties may not accept compensation, in any form, for services performed for the Company from any source other than the Company.

 

·                  No Covered Party may take up any management or other employment position with, or have any material interest in, any firm or company that is in direct or indirect competition with the Company.

 

II.                                   Disclosures

 

The information in the Company’s public communications, including in all reports and documents filed with or submitted to the SEC, must be full, fair, accurate, timely and understandable.

 

To ensure the Company meets this standard, all Covered Parties (to the extent they are involved in the Company’s disclosure process) are required to maintain familiarity with the disclosure requirements, processes and procedures applicable to the Company commensurate with their duties. Covered Parties are prohibited from knowingly misrepresenting, omitting or causing others to misrepresent or omit, material facts about the Company to others, including the Company’s independent auditors, governmental regulators and self-regulatory organizations.

 

(1)  Item 404(a) of SEC Regulation S-K defines “immediate family member” as a person’s child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law, or any person (other than a tenant or employee) sharing the person’s household.

 

2

 

III.                              Compliance with Laws, Rules and Regulations

 

The Company is obligated to comply with all applicable laws, rules and regulations. It is the personal responsibility of each Covered Party to adhere to the standards and restrictions imposed by these laws, rules and regulations in the performance of his or her duties for the Company.

 

The Chief Executive Officer, Chief Financial Officer and Controller (or persons performing similar functions) of the Company (together, the “Senior Financial Officers”) are also required to promote compliance by all employees with the Code and to abide by Company standards, policies and procedures.

 

Covered Parties located outside of the United States must comply with laws, regulations, rules and regulatory orders of the United States, including the Foreign Corrupt Practices Act (“FCPA”) and U.S. export control laws, in addition to applicable local laws.

 

IV.                               Insider Trading

 

Trading on inside information is a violation of federal securities law. Covered Parties in possession of material non-public information about the Company or companies with whom we do business must abstain from trading or advising others to trade in the respective company’s securities from the time that they obtain such inside information until adequate public disclosure of the information. Material information is information of such importance that it can be expected to affect the judgment of investors as to whether or not to buy, sell, or hold the securities in question. To use non-public information for personal financial benefit or to “tip” others, including family members, who might make an investment decision based on this information is not only unethical but also illegal. Covered Parties who trade stock based on insider information can be personally liable for damages totaling up to three times the profit made or loss avoided by the respective Covered Party.

 

V.                                    Reporting, Accountability and Enforcement

 

The Company promotes ethical behavior at all times and encourages Covered Parties to talk to supervisors, managers and other appropriate personnel, including the officers, the General Counsel, outside counsel for the Company and the Board or the relevant committee thereof, when in doubt about the best course of action in a particular situation.

 

Covered Parties should promptly report suspected violations of laws, rules, regulations or the Code or any other unethical behavior by any director, officer, employee or anyone purporting to be acting on the Company’s behalf to appropriate personnel, including officers, the General Counsel, outside counsel for the Company and the Board or the relevant committee thereof. Reports may be made anonymously. If requested, confidentiality will be maintained, subject to applicable law, regulations and legal proceedings.

 

The Audit Committee of the Board shall investigate and determine, or shall designate appropriate persons to investigate and determine, the legitimacy of such reports. The Audit Committee will then determine the appropriate disciplinary action. Such disciplinary action

 

3

 

includes, but is not limited to, reprimand, termination with cause, and possible civil and criminal prosecution.

 

To encourage employees to report any and all violations, the Company will not tolerate retaliation for reports made in good faith. Retaliation or retribution against any Covered Party for a report made in good faith of any suspected violation of laws, rules, regulations or this Code is cause for appropriate disciplinary action.

 

VI.                               Corporate Opportunities

 

Except as otherwise provided in the Company’s certificate of incorporation and bylaws, each as amended from time to time, all Covered Parties owe a duty to the Company to advance the legitimate interests of the Company when the opportunity to do so arises. Covered Parties are prohibited from directly or indirectly (a) taking personally for themselves opportunities that are discovered through the use of Company property, information or positions; (b) using Company property, information or positions for personal gain; or (c) competing with the Company for business opportunities; provided, however, if the Company’s Board determine that the Company will not pursue an opportunity that relates to the Company’s business, a Covered Party may do so, after notifying the Board of intended actions in order to avoid any appearance of conflict of interest.

 

VII.                          Confidentiality

 

In carrying out the Company’s business, Covered Parties may learn confidential or proprietary information about the Company, its customers, distributors, suppliers or joint venture partners. Confidential or proprietary information includes all non-public information relating to the Company, or other companies, that would be harmful to the relevant company or useful or helpful to competitors if disclosed, including financial results or prospects, information provided by a third party, trade secrets, new product or marketing plans, research and development ideas, manufacturing processes, potential acquisitions or investments, or information of use to our competitors or harmful to us or our customers if disclosed.

 

Covered Parties must maintain the confidentiality of all information so entrusted to them, except when disclosure is authorized or legally mandated. Covered Parties must safeguard confidential information by keeping it secure, limiting access to those who have a need to know in order to do their job, and avoiding discussion of confidential information in public areas such as planes, elevators, and restaurants and on mobile phones. This prohibition includes, but is not limited to, inquiries made by the press, analysts, investors or others. Covered parties also may not use such information for personal gain. These confidentiality obligations continue even after employment with the Company ends.

 

VIII.                     Fair Dealing

 

Each Covered Party should endeavor to deal fairly with the Company’s customers, service providers, suppliers, competitors and employees. No Covered Party should take unfair advantage of anyone through manipulation, concealment, abuse of privileged information, misrepresentation of material facts, or any unfair dealing practice. Inappropriate use of

 

4

 

proprietary information, misusing trade secret information that was obtained without the owner’s consent, or inducing such disclosures by past or present employees of other companies is also prohibited.

 

IX.                               Protection and Proper Use of Company Assets

 

All Covered Parties should protect the Company’s assets and ensure their efficient use. Theft, carelessness and waste have a direct impact on the Company’s profitability. All Company assets should be used only for legitimate business purposes. The obligation of employees to protect the Company’s assets includes its proprietary information. Proprietary information includes intellectual property such as trade secrets, patents, trademarks and copyrights, as well as business, marketing and service plans, engineering and manufacturing ideas, designs, databases, records, salary information and any unpublished financial data and reports.

 

X.                                    Waivers

 

Before an employee, or an immediate family member of any such employee, engages in any activity that would be otherwise prohibited by the Code, he or she is strongly encouraged to obtain a written waiver from the Board or the Audit Committee.

 

Before a director or executive officer, or an immediate family member of a director or executive officer, engages in any activity that would be otherwise prohibited by the Code in provisions I through IX above, he or she must obtain a written waiver from the disinterested directors of the Board. Such waiver must then be disclosed to the Company’s stockholders, along with the reasons for granting the waiver.

 

XI.                               Accuracy of Business Records

 

All financial books, records and accounts must accurately reflect transactions and events, and conform both to generally accepted accounting principles (GAAP) and to the Company’s system of internal controls. No entry may be made that intentionally hides or disguises the true nature of any transaction. Covered Parties should therefore attempt to be as clear, concise, truthful and accurate as possible when recording any information.

 

XII.                          Corporate Loans or Guarantees

 

Federal law prohibits the Company to make loans and guarantees of obligations to directors, executive officers, and members of their immediate families.

 

XIII.                     Gifts and Favors

 

The purpose of business gifts and entertainment in a commercial setting is to create goodwill and sound working relationships, not to gain unfair advantage with customers. Covered Parties must act in a fair and impartial manner in all business dealings. Gifts and entertainment should further the business interests of the Company and not be construed as potentially influencing business judgment or creating an obligation.

 

5

 

Gifts must not be lavish or in excess of the generally accepted business practices of one’s country and industry.(2)  Gifts of cash or cash equivalents are never permitted. Requesting or soliciting personal gifts, favors, entertainment or services is unacceptable. Covered Parties should contact the officers, the General Counsel, outside counsel for the Company and the Board or the relevant committee thereof to discuss if they are not certain that a gift is appropriate.

 

The FCPA prohibits giving anything of value, directly or indirectly, to officials of foreign governments or foreign political candidates in order to obtain or retain business. It is strictly prohibited to make illegal payments to government officials of any country. In addition, the promise, offer or delivery to an official or employee of the U.S. government of a gift, favor or other gratuity in violation of these rules would not only violate Company policy but could also be a criminal offense. State and local governments, as well as foreign governments, may have similar rules.

 

XIV.                      Personal Investments

 

Covered Parties may not own, either directly or indirectly, a substantial interest in any business entity that does or seeks to do business with or is in competition with the Company without providing advance notice to the Audit Committee or the General Counsel. Investments in publicly traded securities of companies not amounting to more than one percent (1%) of that company’s total outstanding shares are permitted without such advanced approval.

 

XV.                           Antitrust Laws and Competition

 

The purpose of antitrust laws is to preserve fair and open competition and a free market economy, which are goals that the Company fully supports. Covered Parties must not directly or indirectly enter into any formal or informal agreement with competitors that fixes or controls prices, divides or allocates markets, limits the production or sale of products, boycotts certain suppliers or customers, eliminates competition or otherwise unreasonably restrains trade.

 

XVI.                      Political Contributions

 

Covered Parties may participate in the political process as individuals on their own time. However, Covered Parties must make every effort to ensure that they do not create the impression that they speak or act on behalf of the Company with respect to political matters. Company contributions to any political candidate or party or to any other organization that might

 

(2) In general, no gift, entertainment or business courtesy should be offered, given, provided or accepted unless it: (1) is not a gift of cash, stock or negotiable instruments, (2) is consistent with customary business practices, (3) is not excessive in value, (4) cannot be construed as a bribe or payoff and (5) does not violate any laws or regulations. Covered employees and members of their immediate families may not offer, give or receive gifts from persons or entities who deal with the Company: (a) in those cases where the gift would be illegal or result in a violation of law; (b) as part of an agreement to do anything in return for the gift, (c) if the gift has a value beyond what is normal and customary in the Company’s business; (d) if for directors, the gift is being made to influence the director’s actions as a member of the Board; or (e) if the gift could create the appearance of a conflict of interest.

 

6

 

use the contributions for a political candidate or party are prohibited. A Covered Party may not receive any reimbursement from corporate funds for a personal political contribution.

 

XVII.                 Discrimination and Harassment

 

The Company is an equal opportunity employer and will not tolerate illegal discrimination or harassment of any kind. The Company is committed to providing a workplace free of discrimination and harassment based on race, color, religion, age, gender, national origin, ancestry, sexual orientation, disability, veteran status, or any other basis prohibited by applicable law. Examples include derogatory comments based on a person’s protected class and sexual harassment and unwelcome sexual advances. Similarly, offensive or hostile working conditions created by such harassment or discrimination will not be tolerated.

 

XVIII.            Environmental Protection

 

The Company is committed to managing and operating its assets in a manner that is protective of human health and safety and the environment. It is our policy to comply with both the letter and the spirit of the applicable health, safety and environmental laws and regulations and to attempt to develop a cooperative attitude with government inspection and enforcement officials. Covered Parties are encouraged to report conditions that they perceive to be unsafe, unhealthy or hazardous to the environment.

 

XIX.                      Personal Conduct and Social Media Policy

 

Covered Parties should take care when presenting themselves in public settings, as well as online and in web-based forums or networking sites. Each Covered Party is encouraged to conduct himself or herself in a responsible, respectful, and honest manner at all times. The Company understands that Covered Parties may wish to create and maintain a personal presence online using various forms of social media. However, in so doing Covered Parties should, when and where appropriate, include a disclaimer that the views expressed therein do not necessarily reflect the views of the Company. Covered Parties should be aware that that even after a posting is deleted, certain technology may still make that content available to readers.

 

Covered Parties are prohibited from using or disclosing confidential, proprietary, sensitive or trade secret information of the Company, its partners, vendors, consultants or other third parties with which the Company does business. Harassment of other directors, officers or employees will also not be tolerated. A Covered Party may not provide any content to Company social media sites that may be construed as political lobbying or solicitation of contributions, or use the sites to link to any sites sponsored by or endorsing political candidates or parties, or to discuss political campaigns, political issues or positions on any legislation or law.

 

XX.                           No Rights Created

 

This Code is a statement of certain fundamental principles, policies and procedures that govern the Company’s Covered Parties in the conduct of the Company’s business. It is not intended to and does not create any rights in any employee, customer, client, visitor, supplier,

 

7

 

competitor, stockholder or any other person or entity. It is the Company’s belief that the policy is robust and covers most conceivable situations.

 

8Exhibit 10.36

 

Execution Version

 

CONTROLLING STOCKHOLDERS’ AGREEMENT

 

THIS CONTROLLING STOCKHOLDERS’ AGREEMENT (the “Agreement”), dated as of December 10, 2018, by and among Organogenesis Holdings Inc., a Delaware corporation (the “Company”), and the holders of common stock, par value $0.001 per share (“Common Stock”), of the Company listed on the signature page hereof and on Schedule A, annexed hereto (each a “Stockholder” and, collectively, the “Stockholders”).

 

RECITALS

 

WHEREAS, Avista Healthcare Public Acquisition Corp., a Cayman Islands exempted company (“Parent”, which company subsequently transferred by way of continuation and domesticated as a Delaware corporation, and is now known as the Company), Organogenesis Inc., a Delaware corporation (“Organogenesis”), and Avista Healthcare Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent (“Merger Sub”) entered into an Agreement and Plan of Merger, dated as of August 17, 2018, pursuant to and subject to the terms and conditions of which, among other things, on the date hereof the Company will acquire, by a merger of Merger Sub with and into Organogenesis, all of the outstanding common stock of Organogenesis (the “Acquisition”); and

 

WHEREAS, immediately following the closing of the Acquisition (the “Closing”) and as of the date hereof, the Stockholders own the respective amounts of the issued and outstanding shares of Class A common stock, par value $0.001 per share (the “Common Stock”), set forth in Schedule A to this Agreement;

 

WHEREAS, the shares of Common Stock owned or controlled by the Stockholders collectively represent a significant majority of the voting power of all of the outstanding Common Stock; and

 

WHEREAS, each of the Stockholders believes that it is in their respective best interests to qualify the Company as a “controlled company” under the listing standards of the Nasdaq Stock Market.

 

NOW, THEREFORE, in consideration of the mutual promises and covenants contained in this Agreement, the parties mutually agree as follows:

 

1.                                      DESIGNATION AND VOTING ARRANGEMENTS

 

1.1          Definition of Key Stockholder.  For purposes of this Agreement, the term “Key Stockholder” shall mean each of Alan A. Ades, Albert Erani and Glenn H. Nussdorf, provided, however, that a person shall cease to be a Key Stockholder for all purposes hereunder if he no longer beneficially owns at least 7.5% of the outstanding shares of Common Stock except with respect to Albert Erani, who shall cease to be a Key Stockholder for all purposes hereunder if he and Dennis Erani (or, in the event of Dennis Erani’s death, his estate) collectively no longer beneficially own at least 7.5% of the outstanding shares of Common Stock.  In the event of the death of a Key Stockholder, such Key Stockholder’s estate shall succeed to such Key Stockholder’s rights and obligations hereunder for so long as the estate (and with respect to Albert Erani, his estate and Dennis Erani (or, in the event of Dennis Erani’s death, his estate)

 

1

 

collectively) beneficially owns at least 7.5% of the outstanding shares of Common Stock.  Beneficial ownership hereunder shall be determined in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, as amended.

 

1.2          Designation Right.  The Company hereby acknowledges and agrees that the Company’s Board of Directors (the “Board”) or a committee thereof shall nominate four individuals designated by the Stockholders (the “Designees”) for election at each annual or special meeting of the Company’s stockholders at which an election of directors is held (the “Designation Right”).  The Designation Right of the Stockholders shall be exercised by each Key Stockholder as follows: (i) two Designees shall be designated by Alan A. Ades (or his estate), which Designees shall initially be Alan A. Ades and Maurice Ades; (ii) one Designee shall be designated by Albert Erani (or his estate), which Designee shall initially be Albert Erani; and (iii) one Designee shall be designated by Glenn H. Nussdorf (or his estate), which Designee shall initially be Glenn H. Nussdorf.  The Designation Right shall be subject to applicable rules of the Nasdaq Stock Market and shall be reduced or eliminated if required thereby.  In the absence of any designation from a Key Stockholder who is then entitled to make a designation (on behalf of the Stockholders) as specified above, the Designee or Designees previously designated by such Key Stockholder and then serving shall be re-nominated by the Board or a committee thereof for re-election as a member of the Board.  The Company further acknowledges and agrees that, in the event any Designee or Designees designated by a Key Stockholder (on behalf of the Stockholders) for any reason ceases to serve as a member of the Board during his or her term of office, the Board or a committee thereof shall nominate a new Designee designated by such Key Stockholder (on behalf of the Stockholders) for election to fill the vacant directorship by the Stockholders.  Notwithstanding anything contained herein to the contrary, (a) in the event that a person or his estate ceases to be a Key Stockholder, such person’s right to exercise the Designation Right on behalf of the Stockholders shall automatically terminate upon such event and the Designation Right of the Stockholders shall be reduced by one or more Designees (as applicable) and (b) in the event that either Albert Erani (or his estate) or Glenn H. Nussdorf (or his estate) ceases to have a Designation Right, then Alan A. Ades (or his estate) shall thereafter be entitled to designate one Designee and not two.

 

1.3          Voting.  Each Stockholder shall vote all of the respective shares of Common Stock over which such Stockholder has voting control (including, without limitation, any shares of Common Stock acquired after the date hereof) and shall take all other necessary or desirable actions within such respective Stockholder’s control (including in his or her capacity as a stockholder, trustee or otherwise, and including, without limitation, attendance at meetings in person or by proxy for purposes of obtaining a quorum and/or execution of written consents in lieu of meetings) to vote all such shares of Common Stock so that any persons nominated for election to the Board by the Board (or a committee thereof) and listed in the proxy statement for the annual or special meeting scheduled to elect members of the Board shall be elected to the Board, and, in the event that any such director elected by the Stockholders for any reason ceases to serve as a member of the Board during his or her term of office, another nominee of the Board (or a committee thereof) shall be nominated and elected to fill the vacant directorship by the Stockholders.

 

1.4          Proxy.  In order to secure each Stockholder’s obligation to vote his, her or its shares of Common Stock in accordance with the provisions of Section 1.3, each Stockholder hereby appoints each of Alan A. Ades, Albert Erani and Glenn H. Nussdorf  (each such person,

 

2

 

an “Applicable Proxy”), as his, her or its true and lawful proxy and attorney-in-fact, with full power of substitution, to vote all of such Stockholder’s shares of Common Stock for the election of directors in the manner expressly provided for in Section 1.3.  Each Applicable Proxy may exercise the irrevocable proxy granted to it hereunder at any time any Stockholder fails to comply with the provisions of Section 1.3.  The proxies and powers granted by each Stockholder pursuant to this Section 1.4 are coupled with an interest and are given to secure the performance of the obligations under this Agreement.  Such proxies and powers will be irrevocable until the termination of this Agreement and will survive the death, incompetency and disability of each Stockholder.  It is understood and agreed that each Applicable Proxy will not use such irrevocable proxy unless a Stockholder fails to comply with Section 1.3 and that, to the extent an Applicable Proxy uses such irrevocable proxy, it will only vote such shares of Common Stock with respect to the matters specified in, and in accordance with the provisions of, Section 1.3.

 

2.             POWER OF SALE.

 

Subject to the provisions of any applicable federal or state securities laws and Section 5.5(d) of this Agreement, each of the Stockholders shall have the power, with respect to all or a portion of the shares of Common Stock owned or controlled by such Stockholder, either individually or grouped with other Stockholders, (i) to sell, transfer, assign, pledge, encumber or otherwise dispose of any such shares of Common Stock, and (ii) to exercise or refrain from exercising, or to sell any conversion privilege, warrant, option or subscription right, with respect to such shares of Common Stock.

 

3.             COMPENSATION; EXPENSES.

 

No Stockholder shall be entitled to compensation for acting hereunder.  Each Stockholder will pay his, her or its own individual expenses in complying with this Agreement.

 

4.             TERM; TERMINATION.

 

This Agreement shall have a term beginning on the date hereof and continuing until the earlier to occur of: (i) such time as none of the Key Stockholders beneficially own at least 7.5% of the outstanding shares of Common Stock as provided in Section 1.1 of this Agreement or (ii) the date that is six years and three months after the date of this Agreement.  Notwithstanding the foregoing, this Agreement may be terminated at any time pursuant to a written instrument signed by: (i) the Stockholders who then have voting control over two-thirds of the total outstanding shares of Common Stock held by the Stockholders and (ii) all of the Key Stockholders.

 

5.                                      MISCELLANEOUS.

 

5.1          Amendment. The provisions of this Agreement may be amended by a written instrument signed by the Stockholders who then have voting control over two-thirds of the total outstanding shares of Common Stock covered by this Agreement and each of the Key Stockholders.

 

5.2          Enforceability; Remedies. The parties hereto and the beneficiaries of the respective Stockholders will be irreparably damaged in the event that this Agreement is not specifically enforced. Should any dispute arise as to any vote of any Common Stock or any other action under this Agreement, an injunction may be issued restraining any such vote or other

 

3

 

action pending the determination of such controversy, and in the event a Stockholder fails to follow directions as provided for herein, such Stockholder’s obligation to follow such direction shall be enforceable in a court of equity by a decree of specific performance. Such remedies shall, however, be cumulative and not exclusive and shall be in addition to any other remedy any of the parties hereto may have.

 

5.3          Jurisdiction and Venue. Each party to this Agreement hereby agrees that any action, suit or proceeding arising out of or relating to this Agreement (an “Action”) will be commenced in the Court of Chancery of the State of Delaware. Each party to this Agreement hereby irrevocably consents to the jurisdiction and venue of the Court of Chancery of the State of Delaware in connection with any Action.

 

5.4          Notices. Any notice required or desired to be delivered hereunder shall be (a) in writing; (b) delivered personally, by courier service, by certified or registered mail, return receipt requested, by facsimile or by electronic mail; (c) effective on the date of personal delivery or delivery by courier service, three business days after being placed in the mail, or the next business day after being sent by facsimile or electronic mail (receipt acknowledged electronically); and (d) addressed as designated on Schedule A hereto (or to such other address as the party entitled to notice shall hereafter designate in accordance with the terms hereof), with a copy to:

 

Foley Hoag LLP

155 Seaport Boulevard

Boston, Massachusetts

Attention: William R. Kolb, Esq.

Facsimile: 617-832-1209

E-mail: wkolb@foleyhoag.com

 

5.5          Construction. Except as otherwise provided herein, the provisions of this Agreement shall apply to any successor Stockholder who becomes a party to this Agreement in accordance with Section 5.5(d) of this Agreement, as if such successor were the original Stockholder named herein. All of the provisions of this Agreement shall apply to all shares of Common Stock now owned or hereinafter acquired by the Stockholders. Except as may be provided herein, nothing hereunder shall be deemed to constitute any person a third party beneficiary of this Agreement.

 

(a)           Whenever necessary or appropriate, the use herein of any gender shall be deemed to include the other gender and the use herein of either the singular or the plural shall be deemed to include the other.

 

(b)           The headings and titles herein are for convenience of reference only and are to be ignored in any construction of the provisions hereof.

 

(c)           This Agreement shall be governed and construed according to the laws of the State of Delaware, without regard to its rules for conflicts of laws.

 

(d)           This Agreement shall be binding on the parties hereto and their respective heirs, executors, administrators, successors and assigns. Without limiting the

 

4

 

generality of the preceding sentence, this Agreement shall be binding on any person who hereinafter acquires any shares of Common Stock from a Stockholder or successor Stockholder, including any person who acquires such shares of Common Stock for no consideration, whether by gift, distribution or other transfer, and shall be deemed a Stockholder hereunder; provided that, as a condition to such transfer, any such person shall agree in writing to be bound by the terms and conditions of this Agreement pursuant to an instrument of assumption reasonably satisfactory in substance and form to the Company.  Notwithstanding the foregoing, any person who acquires shares of Common Stock from a Stockholder in an arm’s-length transaction for consideration, including any transfer by a Stockholder of shares of Common Stock via a sale on NASDAQ or another stock exchange, shall not take such shares subject to this Agreement and shall not be deemed a Stockholder hereunder.

 

(e)           This Agreement was prepared by counsel to the Company. Each of the Stockholders has had an opportunity to have the Agreement reviewed by his, her or its own counsel.

 

(f)            This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together can constitute one and the same instrument.

 

[Signature Page Follows]

 

5

 

IN WITNESS WHEREOF, this Agreement has been executed by each of the parties hereto as of the date first above written.

 

	
 
    	
COMPANY:
    
	
 
    	
 
    
	
 
    	
ORGANOGENESIS   HOLDINGS INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Lori Freedman
    
	
 
    	
Name:   Lori Freedman
    
	
 
    	
Title:   Vice President and General Counsel
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
STOCKHOLDERS:
    
	
 
    	
 
    
	
 
    	
ORGANO   PFG LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Alan Ades
    
	
 
    	
Name:   Alan Ades
    
	
 
    	
Title:   Member
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Albert Erani
    
	
 
    	
Name:   Albert Erani
    
	
 
    	
Title:   Member
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
ORGANO   INVESTORS LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Alan Ades
    
	
 
    	
Name:   Alan Ades
    
	
 
    	
Title:   Member
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Albert Erani
    
	
 
    	
Name:   Albert Erani
    
	
 
    	
Title:   Member
    
	
 
    	
 
    
	
 
    	
GN   2016 FAMILY TRUST U/A/D AUGUST 12, 2016
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Michael Katz
    
	
 
    	
Name:   Michael Katz
    
	
 
    	
Title:   Trustee
    

 

 

[Signature Page to Controlling Stockholders’ Agreement]

 

 

	
 
    	
GN   2016 ORGANO 10-YEAR GRAT U/A/D SEPTEMBER 30, 2016
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Glenn Nussdorf
    
	
 
    	
Name:   Glenn Nussdorf
    
	
 
    	
Title:   Trustee
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
DENNIS   ERANI 2012 ISSUE TRUST
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Susan Erani
    
	
 
    	
Name:   Susan Erani
    
	
 
    	
Title:   Trustee
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Glenn Nussdorf
    
	
 
    	
Name:   Glenn Nussdorf
    
	
 
    	
Title:   Trustee
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ David Peretz
    
	
 
    	
Name:   David Peretz
    
	
 
    	
Title:   Trustee
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
ALBERT   ERANI FAMILY TRUST DATED 12/29/2012
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ John Wisdom
    
	
 
    	
Name:   John Wisdom
    
	
 
    	
Title:   Trustee
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Starr Wisdom
    
	
 
    	
Name:   Starr Wisdom
    
	
 
    	
Title:   Trustee
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
ALAN   ADES 2014 GRAT
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Alan Ades
    
	
 
    	
Name:   Alan Ades
    
	
 
    	
Title:   Trustee
    
	
 
    	
 
    
	
 
    	
/s/   Alan A. Ades
    
	
 
    	
Alan   A. Ades
    
	
 
    	
 
    
	
 
    	
/s/   Albert Erani
    
	
 
    	
Albert   Erani
    
	
 
    	
 
    
	
 
    	
/s/   Dennis Erani
    
	
 
    	
Dennis   Erani
    

 

 

[Signature Page to Controlling Stockholders’ Agreement]

 

 

	
 
    	
/s/   Glenn H. Nussdorf
    
	
 
    	
Glenn   H. Nussdorf
    
	
 
    	
 
    
	
 
    	
/s/   Starr Wisdom
    
	
 
    	
Starr   Wisdom
    

 

 

[Signature Page to Controlling Stockholders’ Agreement]

 

 

SCHEDULE A

 

Company Notice Information:

 

Organogenesis Holdings Inc.

85 Dan Road

Canton, MA 02021

Attention: President and CEO

 

	
Stockholders Name
    	
 
    	
Addresses for Notice
    	
 
    	
Shares of
   Common Stock
    
	
Organo PFG LLC
    	
 
    	
c/o A&E Stores, Inc.
   1000 Huyler Street
   Teterboro, NJ 07608
    	
 
    	
32,134,638
    
	
Organo Investors LLC
    	
 
    	
c/o A&E Stores, Inc.
   1000 Huyler Street
   Teterboro, NJ 07608
    	
 
    	
2,851,984
    
	
Alan Ades 2014 GRAT
    	
 
    	
c/o A&E Stores, Inc.
   1000 Huyler Street
   Teterboro, NJ 07608
    	
 
    	
1,489,779
    
	
Albert Erani Family Trust dated 12/29/2012
    	
 
    	
c/o A&E Stores, Inc.
   1000 Huyler Street
   Teterboro, NJ 07608
    	
 
    	
2,731,199
    
	
Dennis Erani 2012 Issue Trust
    	
 
    	
c/o A&E Stores, Inc.
   1000 Huyler Street
   Teterboro, NJ 07608
    	
 
    	
2,964,131
    
	
GN 2016 Family Trust u/a/d August 12, 2016
    	
 
    	
 
    	
 
    	
1,167,250
    
	
GN 2016 Organo 10-Year GRAT u/a/d September 30,   2016
    	
 
    	
 
    	
 
    	
11,012,750
    
	
Alan A. Ades
    	
 
    	
c/o A&E Stores, Inc.
   1000 Huyler Street
   Teterboro, NJ 07608
    	
 
    	
7,989,993
    
	
Albert Erani
    	
 
    	
c/o A&E Stores, Inc.
   1000 Huyler Street
   Teterboro, NJ 07608
    	
 
    	
936,516
    
	
Dennis Erani
    	
 
    	
c/o A&E Stores, Inc.
   1000 Huyler Street
   Teterboro, NJ 07608
    	
 
    	
1,323,523
    
	
Glenn H. Nussdorf
    	
 
    	
 
    	
 
    	
2,658,663
    
	
Starr Wisdom
    	
 
    	
 
    	
 
    	
586,297
    
	
Total
    	
 
    	
N/A
    	
 
    	
67,846,723

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]